Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HADHB pseudogene 1 (HADHBP1) is annotated as a pseudogene related to the HADHB gene, which encodes a functional subunit of the mitochondrial trifunctional enzyme involved in fatty acid beta-oxidation[1][2]. However, as a pseudogene, HADHBP1 does not encode an active protein product and lacks known biological function, clinical relevance, or disease associations. It is not recognized as a therapeutic target and has no known roles in drug interactions, disease, or patient selection biomarkers. Note: The functional gene, HADHB, is involved in several fatty acid oxidation disorders, but HADHBP1 is not itself implicated in these or any other conditions[2]. Thus, classification of HADHBP1 as a therapeutic target or receptor is incorrect; the entry refers to a nonfunctional DNA sequence rather than an active protein or molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta pseudogene 1 (HADHBP1).